Why GLP-1 Medications Are Prescribed GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide are approved for: Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol These medications mimic the GLP-1 hormone, which helps regulate appetite, glucose levels, and insulin secretion
This makes the peptide Retatrutide dosage calculator a reference point not just for Retatrutide, but for other experimental compounds where accuracy and consistency are important
It stimulates L-cells in the lower intestine and colon, encouraging your body to produce more natural GLP-1
Dye-free batches may require additional preparation time, so discuss this preference during your initial consultation with your healthcare provider
A new 2025 real-world cohort study found that people using GLP-1 receptor agonists had a **31% lower risk of developing osteoporosis** compared to non-users (*HR 0.69
with commentary from two of Communes resident female biohackers Schuyler Grant and Cooper Moll
